EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo
EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo is a paper indexed in ScholarIQ from OpenAlex.
How many citations does EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo have?
EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo has 3 citations in the OpenAlex counts ScholarIQ stores.
When was EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo published?
EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo has 2012 year in the ScholarIQ index.
What is the open-access status of EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo?
EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo has closed oa status in the ScholarIQ index.
What is the DOI of EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo?
The DOI for EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo is on the source record.
What is the PMID of EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo?
The PMID for EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo is on the source record.
What is the OpenAlex record for EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo?
The OpenAlex for EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo is on the source record.